Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Charles J. Bruce, M.B., Ch.B. Cardiologist, Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Distinguished Inventor
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Home Bistro Inc.: Exclusive Interview with CEO Zomi Dukkha and Celebrity Chef Dana Falk on Gourmet Meal Delivery Innovations
00:10:00
Prolific investors and inspiring entrepreneurs talk candidly about the complex venture landscape|Armaan Ali,Co-Founder, CEO, and Managing Partner,Human Capital
00:10:00
A Deep Dive into GP Investments: Strategic Insights and Market Perspectives | Antonio Bonchristiano, CEO, GP Investimentos.
00:10:00
Korea's state-run electric power corporation initiates self-rescue measures amid a growing deficit, following its CEO's offer to implement strategic reforms.
00:10:00
Expert Perspectives on Active ETFs and Market Strategies with Noah Hammond | Noah Hamman, CEO , AdvisorShares Investments, LLC.
00:10:00
Germany and Eastern Europe's Collaborative Future | Stefan Hoops, CEO , DWS Group.
00:10:00
From Student Entrepreneurship Advocate to Leading Deep-Tech VC | Peter Hébert, Co-founder, Lux Capital.
00:10:00
Bilibili Inc. Makes Hong Kong Debut as a Major Homecoming for Chinese Tech Firms | Chen Rui, CEO, Bilibili Inc.
00:10:00
"Navigating the 4th Quarter Market Review with Scott Kubie, Senior Investment Strategist at Carson Group | Wealth Management, Inc."
00:10:00
Mayur Resources Explores Growth Opportunities in Papua New Guinea at London Conference
00:10:00
How a Chance Encounter with Robert Kiyosaki’s Book Changed My Life
00:10:00
Navigating Investments Amid the Covid-19 Crisis: An In-Depth Interview with Dr. Savvas Savouri, Chief Investment Officer at Toscafund Asset Management